Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Cancer. 2016 Apr 18;122(13):2091–2100. doi: 10.1002/cncr.30009

Table 3.

Unadjusted and propensity model-adjusted survival outcomes for stereotactic radiosurgery versus whole brain radiation therapy for cohorts with < 4 brain metastases and size of largest brain metastasis < 4 cm.

Non-small cell lung cancer Breast cancer
N Hazard
Ratio
95% CI p-
value
N Hazard
Ratio
95% CI p-
value
Unadjusted 189 0.53 0.38,0.74 <0.001 117 0.70 0.47,1.03 0.07
Adjusted by
propensity score
model
180 0.58 0.38,0.87 0.01 112 0.54 0.33,0.91 0.02
Adjusted by
standardized
mortality ratio
propensity
weighting
180 0.26 0.20,0.34 <0.001 112 0.61 0.45,0.81 <0.00
1